EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study

Christos Koros, Athina-Maria Simitsi, Nikolaos Papagiannakis, Anastasia Bougea, Andreas Prentakis, Dimitra Papadimitriou, Ioanna Pachi, Ion Beratis, Evangelia Stanitsa, Efthalia Angelopoulou, Roubina Antonelou, Marianna Bregianni und 6 weitere

Journal of Parkinson’s Disease · 2023

DOI: 10.3233/jpd-230007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Parkinson’s Disease, 2023. Verfasst von Christos Koros und 17 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Parkinson Disease, REM Sleep Behavior Disorder. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The role of blood uric acid as a biomarker in symptomatic motor PD has been increasingly established in the literature.

Objective

Our present study assessed the role of serum uric acid as a putative biomarker in a prodromal PD cohort [REM Sleep Behavior disorder (RBD) and Hyposmia] followed longitudinally.

Methods

Longitudinal 5-year serum uric acid measurement data of 39 RBD patients and 26 Hyposmia patients with an abnormal DATSCAN imaging were downloaded from the Parkinson’s Progression Markers Initiative database. These cohorts were compared with 423 de novo PD patients and 196 healthy controls enrolled in the same study.

Results

After adjusting for age, sex, body mass index, and concomitant disorders (hypertension/gout), baseline and longitudinal serum uric acid levels were higher in the RBD subgroup as compared to the established PD cohort ( p = 0.004 and p = 0.001). (Baseline RBD 6.07±1.6 vs. Baseline PD 5.35±1.3 mg/dL and Year-5 RBD 5.7±1.3 vs. Year-5 PD 5.26±1.33). This was also true for longitudinal measurements in the Hyposmic subgroup ( p = 0.008) (Baseline Hyposmic 5.7±1.6 vs. PD 5.35±1.3 mg/dL and Year-5 Hyposmic 5.58±1.6 vs. PD 5.26±1.33).

Conclusion

Our results indicate that serum uric acid levels are higher in prodromal PD subjects with ongoing dopaminergic degeneration compared to those with manifest PD. These data indicate that the well-established decrease in the levels of serum uric acid occurs with the transition from prodromal to clinical PD. Whether the higher levels of serum uric acid observed in prodromal PD may provide protection against conversion to full-blown clinical PD will require further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseREM Sleep Behavior DisorderHumansUric AcidAnosmiaBiomarkersProdromal Symptoms

Stichwörter der Autor:innen

Prodromal Parkinson’s diseaseREM sleep behavior disorderhyposmiauric acid

Substanzen

Uric AcidBiomarkers

Autor:innen und Institutionen

  • 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Nuclear Medicine Unit, Attikon Hospital, Athens, Greece.
  • Neurology Clinic, Henry Dunan Hospital, Athens, Greece.
  • 2nd Department of Neurology, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Neurology Clinic, Philipps University, Marburg, Germany.
  • Parkinsons disease and Movement Disorders Dept., HYGEIA Hospital, Athens, Greece.

Zitieren

APA

Koros, C., Simitsi, A. M., Papagiannakis, N., Bougea, A., Prentakis, A., Papadimitriou, D., Pachi, I., Beratis, I., Stanitsa, E., Angelopoulou, E., Antonelou, R., Bregianni, M., Lourentzos, K., Papageorgiou, S. G., Bonakis, A., Trapali, X. G., Stamelou, M., & Stefanis, L. (2023). Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-230007

Vancouver

Koros C, Simitsi AM, Papagiannakis N, Bougea A, Prentakis A, Papadimitriou D, et al. Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study. Journal of Parkinson’s Disease. 2023. doi:10.3233/jpd-230007

BibTeX
@article{Koros2023,
  author = {Koros, Christos and Simitsi, Athina-Maria and Papagiannakis, Nikolaos and Bougea, Anastasia and Prentakis, Andreas and Papadimitriou, Dimitra and Pachi, Ioanna and Beratis, Ion and Stanitsa, Evangelia and Angelopoulou, Efthalia and Antonelou, Roubina and Bregianni, Marianna and Lourentzos, Konstantinos and Papageorgiou, Sokratis G and Bonakis, Anastasios and Trapali, Xenia Geronicola and Stamelou, Maria and Stefanis, Leonidas},
  title = {Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study},
  journal = {Journal of Parkinson’s Disease},
  year = {2023},
  doi = {10.3233/jpd-230007}
}
Kostenlos starten →